Invion Limited (ASX:IVX – Get Free Report) insider Chiat Chew acquired 17,861,942 shares of Invion stock in a transaction that occurred on Wednesday, September 4th. The stock was bought at an average price of A$0.00 ($0.00) per share, for a total transaction of A$35,723.88 ($23,815.92).
Invion Stock Performance
About Invion
Invion Limited, a clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of various cancers, atherosclerosis, and infectious diseases in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, anogenital, and mesothelioma cancers.
See Also
- Five stocks we like better than Invion
- Dividend Payout Ratio Calculator
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- Are Penny Stocks a Good Fit for Your Portfolio?
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- 3 REITs to Buy and Hold for the Long Term
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for Invion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invion and related companies with MarketBeat.com's FREE daily email newsletter.
